BioReference Laboratories
Labcorp to Acquire Select Assets of BioReference Health for $237.5M
Under the deal, Labcorp will acquire BioReference's laboratory testing businesses focused on clinical diagnostics and reproductive and women's health in certain states.
Earnings Roundup: OraSure Technologies, Opko Health, Biodesix, Sophia Genetics,
OraSure, Opko, Sophia Genetics, and Biodesix reported their third quarter financial results this week.
In Brief This Week: PerkinElmer, CDC, Opko, DermTech, OpGen, More
News items for the week of May 1, 2023.
In Brief This Week: Abbott, Thermo Fisher Scientific, Danaher, Oncocyte, Biocartis, More
News items for the week of Feb. 20, 2023.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
Oct 20, 2022
Aug 31, 2022
Oct 28, 2021
Opko Health Q3 Revenues Fall 10 Percent
Sep 2, 2021
May 6, 2021
Apr 29, 2021